Theolytics Limited
Clinical trials sponsored by Theolytics Limited, explained in plain language.
-
Virus therapy targets Hard-to-Treat ovarian cancer in early trial
Disease control Recruiting nowThis early-stage trial tests a new treatment called THEO-260, a virus designed to attack cancer cells, in people with advanced ovarian cancer that no longer responds to platinum chemotherapy. The study aims to find a safe dose and see if the treatment can shrink tumors. About 18 …
Phase: PHASE1 • Sponsor: Theolytics Limited • Aim: Disease control
Last updated May 26, 2026 10:30 UTC
-
Virus therapy takes on ovarian cancer: new hope in early trial
Disease control Recruiting nowThis study tests a new treatment called THEO-260, a virus designed to attack cancer cells, in people with advanced ovarian cancer. About 44 participants will receive different doses to find the safest and most effective one. The goal is to control the disease and reduce tumors, n…
Phase: PHASE1, PHASE2 • Sponsor: Theolytics Limited • Aim: Disease control
Last updated May 14, 2026 12:02 UTC